Yield10 Bioscience, Inc. (YTEN) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
November 14, 2023 4:01 PM EST-Establishes "Camelina Seed Genetics to Biofuel" Platform-Advances Herbicide Tolerant Camelina Varieties toward Commercialization-Exercises Option to Finalize Exclusive, Global Commercial License to Advanced Omega-3 Technology-Management will host a conference call today at 4:30 pm (ET)
WOBURN, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2023.
During the third quarter of 2023, we established our Camelina Seed Genetics to Biofuel platform as we completed the harvest of spring and... More



